{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:52:38Z","timestamp":1787961158886,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974271"],"award-info":[{"award-number":["81974271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.phymed.2026.158328","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:52:04Z","timestamp":1779429124000},"page":"158328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antitumor and resensitizing effects of wogonin in thyroid cancer via PDGFRB-dependent mechanisms"],"prefix":"10.1016","volume":"157","author":[{"given":"Xinqi","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158328_bib0001","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2026.158328_bib0002","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/ptr.7386","article-title":"Wogonin and its analogs for the prevention and treatment of cancer: a systematic review","volume":"36","author":"Banik","year":"2022","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2026.158328_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bioorg.2018.08.028","article-title":"Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity","volume":"81","author":"Bian","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phymed.2026.158328_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1153991","article-title":"Lenvatinib resistance mechanism and potential ways to conquer","volume":"14","author":"Bo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158328_bib0004","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S1470-2045(21)00332-6","article-title":"Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"22","author":"Brose","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2026.158328_bib0005","first-page":"26","article-title":"Natural compounds targeting MAPK, PI3K\/Akt, and JAK\/STAT signaling in papillary thyroid cancer","author":"Carnazza","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158328_bib0006","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2026.158328_bib34","doi-asserted-by":"crossref","first-page":"1546285","DOI":"10.3389\/fphar.2025.1546285","article-title":"Wogonin inhibits the proliferation of prolactinoma through the PI3K\/AKT signaling pathway","volume":"16","author":"Du","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158328_bib0007","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/thy.2022.0704","article-title":"Challenges and strategies to combat resistance mechanisms in thyroid cancer therapeutics","volume":"33","author":"Gild","year":"2023","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.phymed.2026.158328_bib0008","first-page":"23","article-title":"NCCN guidelines\u00ae insights: thyroid carcinoma, version 1.2025","author":"Haddad","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.phymed.2026.158328_bib0009","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1007\/s11033-020-05972-9","article-title":"Potential therapeutic and pharmacological effects of Wogonin: an updated review","volume":"47","author":"Huynh","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phymed.2026.158328_bib0010","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1210\/clinem\/dgab552","article-title":"Lenvatinib targets PDGFR-\u03b2 pericytes and inhibits synergy with thyroid carcinoma cells: novel translational insights","volume":"106","author":"Iesato","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2026.158328_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117103","article-title":"Wogonin induces mitochondrial apoptosis and synergizes with venetoclax in diffuse large B-cell lymphoma","volume":"492","author":"Lin","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158328_bib0012","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1142\/S0192415X24500460","article-title":"Wogonin inhibits colorectal cancer proliferation and epithelial mesenchymal transformation by suppressing phosphorylation in the AKT pathway","volume":"52","author":"Liu","year":"2024","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2026.158328_bib35","doi-asserted-by":"crossref","first-page":"1129662","DOI":"10.3389\/fphar.2023.1129662","article-title":"Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2\/GPX4 axis","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158328_bib0013","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1158\/1078-0432.CCR-24-1750","article-title":"MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-deficient malignant peripheral nerve sheath tumor","volume":"30","author":"Miranda-Rom\u00e1n","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158328_bib0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2017.02.026","article-title":"Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma","volume":"395","author":"Neri","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158328_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/ml500394m","article-title":"Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization","volume":"6","author":"Okamoto","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2026.158328_bib0016","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.phymed.2026.158328_bib0017","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1042\/BST20200004","article-title":"The emerging complexity of PDGFRs: activation, internalization and signal attenuation","volume":"48","author":"Rogers","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phymed.2026.158328_bib0018","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phrs.2018.01.021","article-title":"The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders","volume":"129","author":"Roskoski","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2026.158328_bib0019","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(13)70215-8","article-title":"Definition and management of radioactive iodine-refractory differentiated thyroid cancer","volume":"2","author":"Schlumberger","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.phymed.2026.158328_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158328_bib0021","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s41417-024-00781-9","article-title":"IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK\/STAT signaling pathway","volume":"31","author":"Shi","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.phymed.2026.158328_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81196-2","article-title":"Wogonin suppresses proliferation, invasion and migration in gastric cancer cells via targeting the JAK-STAT3 pathway","volume":"14","author":"Song","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158328_bib0023","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1593\/neo.121726","article-title":"PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells","volume":"15","author":"Steller","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.phymed.2026.158328_bib0024","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s10555-024-10194-7","article-title":"Functional and clinical roles of stromal PDGF receptors in tumor biology","volume":"43","author":"Strell","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.phymed.2026.158328_bib0025","first-page":"27","article-title":"Plants as a source of anticancer agents: from bench to bedside","author":"Talib","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2026.158328_bib0026","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/15353702231179961","article-title":"Wogonin, as a potent anticancer compound: from chemistry to cellular interactions","volume":"248","author":"Tuli","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.phymed.2026.158328_bib0027","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3389\/fphar.2020.01152","article-title":"Wogonin induces apoptosis and reverses sunitinib resistance of renal cell carcinoma cells via inhibiting CDK4-RB pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158328_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111501","article-title":"PDGFRB promotes dedifferentiation and pulmonary metastasis through rearrangement of cytoskeleton under hypoxic microenvironment in osteosarcoma","volume":"125","author":"Xu","year":"2025","journal-title":"Cell Signal."},{"key":"10.1016\/j.phymed.2026.158328_bib36","doi-asserted-by":"crossref","first-page":"112515","DOI":"10.1016\/j.colsurfb.2022.112515","article-title":"Improved stability and pharmacokinetics of wogonin through loading into PASylated ferritin","volume":"216","author":"Yang","year":"2022","journal-title":"Colloids Surf. B. Biointer."},{"key":"10.1016\/j.phymed.2026.158328_bib0029","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/mc.23856","article-title":"Wogonin inhibits ovarian cancer by activating the AMPK-TET2-5hmC axis","volume":"64","author":"Yang","year":"2025","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.phymed.2026.158328_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12032-023-02295-0","article-title":"Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity","volume":"41","author":"You","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.phymed.2026.158328_bib0031","article-title":"Molecular basis and targeted therapy in thyroid cancer: progress and opportunities","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158328_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114500","article-title":"Targeted therapy and drug resistance in thyroid cancer","volume":"238","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2026.158328_bib0033","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","article-title":"Targeting the PDGF\/PDGFR signaling pathway for cancer therapy: a review","volume":"202","author":"Zou","year":"2022","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326005611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326005611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:37:26Z","timestamp":1783046246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326005611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S0944711326005611"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158328","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor and resensitizing effects of wogonin in thyroid cancer via PDGFRB-dependent mechanisms","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158328"}}